26 reports

The same study also shows diabetes, high cholesterol, heart disease, high blood pressure, sleep apnea, asthma, cancer, depression and strokes to be linked to obesity drugs.

  • Obesity
  • Pathology
  • North America
  • World
  • Forecast

Asthma, COPD, Others) The report contains segmentation of the global market for the industry, including market estimates by region, with country level information as well.

  • Obesity
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast

METHODOLOGY FLOW FIGURE ##: METHODOLOGY FLOW FOR DATAMONITOR HEALTHCARE' S ACS FORECAST Acute coronary syndrome Disease Coverage | Forecast: Acute Coronary Syndrome EPIDEMIOLOGY The starting point for Datamonitor Healthcare' s patient-based asthma forecast is estimated diagnosed pati

  • Obesity
  • Europe
  • AstraZeneca PLC
  • NSTEMI group
  • The Medicines Company

GlaxoSmithKline has a diversified portfolio of products and provides assistance in treating major diseases such as asthma, cancer, infections, mental health, diabetes, and digestive conditions and viral diseases.

  • Obesity
  • United States
  • Arena Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

IN SEPARATE CLINICAL STUDIES EVALUATING WEIGHT REDUCTION IN RELATION TO OBESITY-RELATED COMORBIDITIES, WEIGHT LOSS DUE TO THE USE OF THE LAP-BAND WAS DEMONSTRATED TO HELP IMPROVE CONDITIONS SUCH AS ASTHMA (##% IN ## PATIENTS), DIABETES (##% IN ## PATIENTS), GASTROESOPHAGEAL REFLUX (##% IN ##

  • Obesity
  • United States
  • EnteroMedics Inc.
  • Novo Nordisk Group
  • VIVUS, Inc.

The clinical trials of its probiotic products for HIV, acute diverticulitis, rhinitis, asthma, and grass allergy are nearing completion.

  • Obesity
  • North America
  • World
  • Market Size
  • Yakult Honsha Co., Ltd.

CINNAMON SUPPLEMENTS ARE ALREADY BEING SOLD AS PREVENTATIVE OR Adverse Effects THERAPEUTIC SUPPLEMENT FOR VARIOUS DISEASES, INCLUDING T##D, METABOLIC SYNDROME, INSULIN RESISTANCE, ASTHMA, ARTHRITIS, CANCER AND ELEVATED CHOLESTEROL.

  • Diabetes
  • Insulin
  • Obesity
  • Spice
  • World

Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others.

  • Obesity
  • United States
  • World
  • Product Initiative
  • Biophytis
  • DYSLIPIDEMIA - PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2017
  • DYSLIPIDEMIA - PIPELINE BY SAMJIN PHARMACEUTICAL CO LTD, H1 2017

Its KETAS is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Cholesterol
  • Obesity
  • Pharmaceutical
  • United States
  • Esperion Therapeutics, Inc.

Regeneron is also developing various product candidates in clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Obesity
  • United States
  • World
  • Product Initiative
  • Biophytis

Sunovion' s products are used in the treatment of schizophrenia, bipolar depression, insomnia, epilepsy, asthma, allergies and COPD.

  • Insulin
  • Obesity
  • United States
  • Company
  • Novo Nordisk Group

According to the American Academy of Allergy, Asthma & Immunology (AAAAI), from 2011 to 2014, the prevalence rate of asthma was ##. ##% among all adults in the U. S.

  • Obesity
  • Europe
  • World
  • Market Size
  • Omada Health, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Health Care Provider
  • Obesity
  • United States
  • GlobalData's company
  • TYPE 2 DIABETES - PIPELINE BY ZYDUS CADILA HEALTHCARE LIMITED, H2 2016
  • OBESITY - PIPELINE BY ORBIS BIOSCIENCES INC, H2 2016

Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others.

  • Biotechnology
  • Obesity
  • Company
  • Product Initiative
  • AstraZeneca PLC

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Hospital
  • Obesity
  • United States
  • GlobalData's company
  • Latest Clinical Trials News on Abdominal Obesity

About LIPO-## LIPO-## is an injectable formulation of salmeterol xinafoate, a well-known long-acting ß##-adrenergic receptor agonist used in several FDA-approved drugs, including ADVAIR for asthma.

  • Obesity
  • Pathology
  • World
  • Product Initiative
  • Neothetics, Inc.
  • INV-88 - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT D5D FOR DIABETES AND OBESITY - DRUG PROFILE

WhanIn Pharma' s offers pipeline products under development for the treatment of asthma, stroke, obesity, dementia and Hepatitis C.

  • Diabetes
  • Obesity
  • United States
  • Company
  • Product Initiative

GPR##/ TDAG## has been linked to several types of cancer and to inflammatory disorders, such as asthma.

  • Cardiology
  • Obesity
  • R&D
  • United States
  • Omeros Corporation

Ibudilast has been used in asthma and post-stroke disorders in Japan for around ## years.

  • Addictions
  • Obesity
  • Opioid
  • United States
  • Product Initiative

Ibudilast has been used in asthma and post-stroke disorders in Japan for around ## years.

  • Addictions
  • Obesity
  • Opioid
  • United States
  • Product Initiative

Asthma, Infectious Fever, wheezing Ongoing, recruiting Phase II Interventional Polyherbal National Institute of Siddha ## Jun 2014 ## Jun 2015 ## ## ## IGF-## and Bone Loss in Women with Anorexia Nervosa IGF-## and Bone Loss in Women with Anorexia Nervosa GDCT## NCT##, ##R##DK## C

  • Eating Disorder
  • Obesity
  • World
  • Product Initiative
  • Shire plc

LIPO-## is an injectable formulation of salmeterol xinafoate, a well-known long-acting ß##-adrenergic receptor agonist used in several FDA-approved drugs, including ADVAIR® for asthma.

  • Obesity
  • Therapy
  • United States
  • Product Initiative
  • Genfit SA

Nuvance was under development for the treatment of asthma.

  • Monoclonal Antibody
  • Obesity
  • Therapy
  • United States
  • Amgen Inc.
  • ABEOME CORPORATION
  • OBESITY - PIPELINE BY ABEOME CORPORATION, H2 2016

WhanIn Pharma' s offers pipeline products under development for the treatment of asthma, stroke, obesity, dementia and Hepatitis C.

  • Obesity
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

It was also under development for the treatment of asthma.

  • Obesity
  • R&D
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company
  • 10.2 PEST ANALYSIS

Obesity is likely to lead to diseases such as asthma, diabetes, and cardiovascular disorders at an earlier age, and is thus an issue of concern for governments.

  • Fitness
  • Obesity
  • Weight Loss
  • Market Size
  • Technogym S.p.A.